[go: up one dir, main page]

NO20010833L - Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler - Google Patents

Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler

Info

Publication number
NO20010833L
NO20010833L NO20010833A NO20010833A NO20010833L NO 20010833 L NO20010833 L NO 20010833L NO 20010833 A NO20010833 A NO 20010833A NO 20010833 A NO20010833 A NO 20010833A NO 20010833 L NO20010833 L NO 20010833L
Authority
NO
Norway
Prior art keywords
composition
component
mucoadhesive compositions
active ingredients
compositions containing
Prior art date
Application number
NO20010833A
Other languages
English (en)
Other versions
NO20010833D0 (no
Inventor
Douglas Joseph Dobrozsi
Todd Ehren Vienneau
Christopher Robert Mayer
Kishorkumar Jivanlal Desai
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20010833L publication Critical patent/NO20010833L/no
Publication of NO20010833D0 publication Critical patent/NO20010833D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Den foreliggende oppfinnelse vedrører mukoadhesive sammensetninger omfattende en sikker og effektive mengde av en gastrointestinal aktiv bestanddel; fra ca 1,5% til ca 10% basert på vekt av sammensetningen, av en leirekomponent; og fra ca 0,01% til ca 1% basert på vekt av sammensetingen, av en gummikomponent. Alternativt kan leirekomponenten være en titandioksid- eller en silisiumdioksidkomponent. De mukoadhesive sammensetninger omfatter også fortrinnsvis opp til ca 2% basert på vekt av sammensetningen, av en ikke- ionisk komponent slik som metylcellulose. Den foreliggende oppfinnelse vedrører også en fremgangsmåte for å forebygge og behandle gastrointestinale systemforstyrrelser i mennesker eller laverestående dyr ved å oralt administrere en sammenseting av den foreliggende oppfinnelse.
NO20010833A 1998-08-24 2001-02-19 Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler NO20010833D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9757698P 1998-08-24 1998-08-24
PCT/US1999/019140 WO2000010527A1 (en) 1998-08-24 1999-08-24 Oral mucoadhesive compositions containing gastrointestinal actives

Publications (2)

Publication Number Publication Date
NO20010833L true NO20010833L (no) 2001-02-19
NO20010833D0 NO20010833D0 (no) 2001-02-19

Family

ID=22264116

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010833A NO20010833D0 (no) 1998-08-24 2001-02-19 Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler

Country Status (15)

Country Link
US (1) US20010016577A1 (no)
EP (1) EP1115378A1 (no)
JP (1) JP2002523352A (no)
KR (1) KR20010072463A (no)
CN (1) CN1313755A (no)
AU (1) AU5685299A (no)
BR (1) BR9913227A (no)
CA (1) CA2338688A1 (no)
CO (1) CO5140071A1 (no)
HU (1) HUP0103216A2 (no)
ID (1) ID27728A (no)
NO (1) NO20010833D0 (no)
PE (1) PE20000860A1 (no)
TR (1) TR200100629T2 (no)
WO (1) WO2000010527A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801791B1 (fr) * 1999-12-03 2003-05-30 Elpronat Composition pour animaux contenant du salicylate de methyle
DK1474109T3 (da) * 2001-12-21 2010-10-25 Alcon Inc Anvendelse af syntetiske uorganiske nanopartikler som bærere af ophthalmiske lægemidler
CA2500218A1 (en) * 2002-09-26 2004-04-08 Yamanouchi Pharmaceutical Co., Ltd. Drug absorptivity improving agent
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) * 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US9050368B2 (en) * 2007-11-13 2015-06-09 Meritage Pharma, Inc. Corticosteroid compositions
SI2211896T1 (en) 2007-11-13 2018-04-30 Meritage Pharma, Inc. Ingredients for the treatment of gastrointestinal inflammation
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
DE102008019339A1 (de) * 2008-04-16 2009-10-22 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum
EP2461863B1 (en) * 2009-08-05 2016-07-27 Covidien LP Surgical wound dressing incorporating connected hydrogel beads having an embedded electrode therein
EP2386289A1 (en) * 2010-04-29 2011-11-16 Ipsen Pharma S.A.S. Clay compositions
EP2654673A1 (en) * 2010-12-23 2013-10-30 Colgate-Palmolive Company Fluid compositions comprising a structuring agent
JP2015504040A (ja) 2011-12-15 2015-02-05 コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ 水性オーラルケア組成物
US20140178456A1 (en) * 2012-08-30 2014-06-26 Udaya Sankar Devanaboyina Methods and compositions for treating type 2 diabetes and related conditions
CN104822707B (zh) * 2012-12-03 2019-11-01 高露洁-棕榄公司 基于结冷胶的流体胶的制备方法
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
WO2015168242A1 (en) * 2014-04-29 2015-11-05 The Procter & Gamble Company Bismuth-containing liquid pharmaceutical suspensions
PL3137059T3 (pl) * 2014-04-29 2018-10-31 The Procter & Gamble Company Metoda wytwarzania płynnych zawiesin farmaceutycznych zawierających bizmut
EP3169374B1 (en) * 2014-07-14 2022-01-05 University of Utah Research Foundation In situ solidifying complex coacervates and methods of making and using thereof
JP2017178881A (ja) * 2016-03-31 2017-10-05 小林製薬株式会社 経口組成物
JP6950312B2 (ja) * 2017-07-12 2021-10-13 ライオン株式会社 液体医薬組成物及び医薬品
JP2019064980A (ja) * 2017-10-03 2019-04-25 小林製薬株式会社 逆流性食道炎改善剤
CA3089480A1 (en) 2018-01-26 2019-08-01 Fluidx Medical Technology, Llc Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
GB9114950D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
WO1994020074A1 (en) * 1993-03-12 1994-09-15 The Procter & Gamble Company Adsorbate compositions

Also Published As

Publication number Publication date
KR20010072463A (ko) 2001-07-31
US20010016577A1 (en) 2001-08-23
ID27728A (id) 2001-04-26
PE20000860A1 (es) 2000-09-11
HUP0103216A2 (hu) 2002-01-28
EP1115378A1 (en) 2001-07-18
NO20010833D0 (no) 2001-02-19
WO2000010527A1 (en) 2000-03-02
JP2002523352A (ja) 2002-07-30
CN1313755A (zh) 2001-09-19
CA2338688A1 (en) 2000-03-02
TR200100629T2 (tr) 2001-07-23
BR9913227A (pt) 2001-05-22
AU5685299A (en) 2000-03-14
CO5140071A1 (es) 2002-03-22

Similar Documents

Publication Publication Date Title
NO20010833L (no) Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler
BE2015C026I2 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
NO982414L (no) Ny kombinasjon
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
ATE525061T1 (de) Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
NO952863D0 (no) Fluoxetin-farmasöytiske sammensetninger
NO20052335L (no) Dispergerbare deferacirox-tabletter
NO20010486L (no) Betennelseshemmende tannpleiemidler
CA2378428A1 (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
PT814789E (pt) Composicoes farmaceuticas compreendendo inibidores de monoamina-oxidase b
AR024240A1 (es) COMPUESTOS DE 4-(AMINOMETIL)-PIPERIDIN BENZAMIDA uTILES PARA TRATAR TRASTORNOS GASTROINTESTINALES, COMPOSICIoN FARMACÉUTICA QUE LOS COMPRENDE, PROCESO PARA PREPARAR DICHA COMPOSICIoN FARMACÉUTICA, COMPUESTO INTERMEDIARIO uTIL PARA PREPARA DICHOS COMPUESTOS DE BENZAMIDA, PROCESO PARA PREPARAR DICHOS
WO2003045326A3 (en) Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
WO2000040232A3 (en) Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
NO20005981L (no) Anvendelse av 2-hydroksy-4-trifluorbenzosyrederivater som inhibitorer av aktivering av den nukleære transkripsjonsfaktor NF- <kappa>B
NO975726D0 (no) N-Hydroksyurea-derivater som anti-inflammatoriske midler
HUP0100390A2 (hu) Eljárás baktericid hatás kifejtésére baktericid zsírsavszappan-frakciót tartalmazó készítmény alkalmazásával
FR2719771B1 (fr) Compositions pharmaceutiques contenant du gemfibrozil.
CA2348693A1 (en) Natural formulation for the treatment and prevention of depression, containing st john's wort and derivatives of dihydro- and tetrahydrofolic acid
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
NO20022971L (no) Butyndiol-derivater
US20120094882A1 (en) Denture Cleanser
ATE473962T1 (de) C2-disubstituierte indan-1-one und ihre derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
RU98114982A (ru) Состав, содержащий диосгенин
NO20073728L (no) Oral umiddelbar frigivelsesformulering av en darlig vannloselig aktiv substans

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application